Methods for diagnosis of encephalitis
View Patent ↗This invention provides methods of diagnosing or determining a cause of an autoimmune encephalitis or an epilepsy in a subject and of diagnosing a tumor in a subject, comprising the step of testing a biological sample of the subject for an antibody to an NR1 subunit of the NMDA receptor. This invention further provides methods of treating an autoimmune encephalitis or an epilepsy, comprising the steps of detecting an antibody to an NR1 subunit of the NMDA receptor and treating a tumor associated with the disease.
1. A method of diagnosing an autoimmune encephalitis in a subject, comprising the steps of obtaining a serum or cerebrospinal fluid (CSF) sample from said subject; and testing said sample for an antibody to an NR1 subunit of an N-methyl D-aspartate (NMDA) receptor, whereby the presence of said antibody in said sample indicates said autoimmune encephalitis, thereby diagnosing said autoimmune encephalitis in said subject, wherein said NR1 subunit comprises the amino acid sequence set forth in SEQ ID NO: 1.
2. The method of claim 1 , whereby said antibody binds to extra cellular N-terminal domain of said NR1 subunit.
3. The method of claim 2 , whereby said antibody binds to a region comprising amino acids 25-380 of SEQ ID NO: 1.
4. The method of claim 2 , whereby said antibody binds to a region comprising a functional fragment of amino acid sequence of SEQ ID NO: 1.
5. The method of claim 1 , whereby said autoimmune encephalitis is an anti-NMDA receptor encephalitis.
6. The method of claim 1 , whereby said autoimmune encephalitis is associated with pathological symptoms.
7. The method of claim 6 , whereby the symptoms are seizures; psychiatric symptoms; abnormality in cognition and behavior; a movement disorder or abnormal movements; a decreased level of consciousness; hypoventilation; amnesia or a memory deficit; or a combination thereof.